268 related articles for article (PubMed ID: 10719305)
21. Novel and recurrent mutations in the C1NH gene of Arab patients affected with hereditary angioedema.
Faiyaz-Ul-Haque M; Al-Gazlan S; Abalkhail HA; Al-Abdulatif A; Toulimat M; Peltekova I; Khaliq AM; Al-Dayel F; Zaidi SH
Int Arch Allergy Immunol; 2010; 151(2):149-54. PubMed ID: 19752569
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema.
Davis AE; Bissler JJ; Cicardi M
Behring Inst Mitt; 1993 Dec; (93):313-20. PubMed ID: 8172583
[TBL] [Abstract][Full Text] [Related]
23. C1 inhibitor mutations which affect intracellular transport and secretion in type I hereditary angioedema.
Verpy E; Couture-Tosi E; Tosi M
Behring Inst Mitt; 1993 Dec; (93):120-4. PubMed ID: 8172558
[TBL] [Abstract][Full Text] [Related]
24. SERPING1 mutations in 59 families with hereditary angioedema.
López-Lera A; Garrido S; Roche O; López-Trascasa M
Mol Immunol; 2011 Oct; 49(1-2):18-27. PubMed ID: 21864911
[TBL] [Abstract][Full Text] [Related]
25. Restriction fragment length polymorphism analysis of the C1-inhibitor gene in hereditary C1-inhibitor deficiency.
McPhaden AR; Birnie GD; Whaley K
Clin Genet; 1991 Mar; 39(3):161-71. PubMed ID: 1674681
[TBL] [Abstract][Full Text] [Related]
26. Hereditary angioedema nationwide study in Slovenia reveals four novel mutations in SERPING1 gene.
Rijavec M; Korošec P; Šilar M; Zidarn M; Miljković J; Košnik M
PLoS One; 2013; 8(2):e56712. PubMed ID: 23437219
[TBL] [Abstract][Full Text] [Related]
27. Hereditary Angioedema Due to C1 Inhibitor Deficiency in Serbia: Two Novel Mutations and Evidence of Genotype-Phenotype Association.
Andrejević S; Korošec P; Šilar M; Košnik M; Mijanović R; Bonači-Nikolić B; Rijavec M
PLoS One; 2015; 10(11):e0142174. PubMed ID: 26535898
[TBL] [Abstract][Full Text] [Related]
28. Hereditary angioedema with a de novo mutation of exon 8 in the C1 inhibitor gene showing recurrent edema of the hands around the peripheral joints: importance for the differential diagnosis of joint swelling.
Sugiyama E; Ozawa T; Taki H; Maruyama M; Yamashita N; Ohta M; Hirata M; Kobayashi M
Arthritis Rheum; 2001 Apr; 44(4):974-7. PubMed ID: 11315937
[TBL] [Abstract][Full Text] [Related]
29. First case of homozygous C1 inhibitor deficiency.
Blanch A; Roche O; Urrutia I; Gamboa P; Fontán G; López-Trascasa M
J Allergy Clin Immunol; 2006 Dec; 118(6):1330-5. PubMed ID: 17137866
[TBL] [Abstract][Full Text] [Related]
30. Hereditary angioedema in Greek families caused by novel and recurrent mutations.
Speletas M; Boukas K; Papadopoulou-Alataki E; Tsitsami E; Germenis AE
Hum Immunol; 2009 Nov; 70(11):925-9. PubMed ID: 19706314
[TBL] [Abstract][Full Text] [Related]
31. Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema.
Gösswein T; Kocot A; Emmert G; Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Bork K; Oldenburg J; Müller CR
Cytogenet Genome Res; 2008; 121(3-4):181-8. PubMed ID: 18758157
[TBL] [Abstract][Full Text] [Related]
32. Altered C1 inhibitor genes in type I hereditary angioedema.
Stoppa-Lyonnet D; Tosi M; Laurent J; Sobel A; Lagrue G; Meo T
N Engl J Med; 1987 Jul; 317(1):1-6. PubMed ID: 3587308
[TBL] [Abstract][Full Text] [Related]
33. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor.
Dewald G; Bork K
Biochem Biophys Res Commun; 2006 May; 343(4):1286-9. PubMed ID: 16638441
[TBL] [Abstract][Full Text] [Related]
34. Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications.
Gadek JE; Hosea SW; Gelfand JA; Frank MM
J Clin Invest; 1979 Jul; 64(1):280-6. PubMed ID: 376558
[TBL] [Abstract][Full Text] [Related]
35. The Turkish Hereditary Angioedema Pilot Study (TURHAPS): the first Turkish series of hereditary angioedema.
Kesim B; Uyguner ZO; Gelincik A; Mete Gökmen N; Sin AZ; Karakaya G; Erdenen F; Ardeniz O; Ozşeker F; Gülbahar O; Colakoğlu B; Dal M; Büyüköztürk S
Int Arch Allergy Immunol; 2011; 156(4):443-50. PubMed ID: 21832835
[TBL] [Abstract][Full Text] [Related]
36. Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.
Wagenaar-Bos IG; Drouet C; Aygören-Pursun E; Bork K; Bucher C; Bygum A; Farkas H; Fust G; Gregorek H; Hack CE; Hickey A; Joller-Jemelka HI; Kapusta M; Kreuz W; Longhurst H; Lopez-Trascasa M; Madalinski K; Naskalski J; Nieuwenhuys E; Ponard D; Truedsson L; Varga L; Nielsen EW; Wagner E; Zingale L; Cicardi M; van Ham SM
J Immunol Methods; 2008 Sep; 338(1-2):14-20. PubMed ID: 18655790
[TBL] [Abstract][Full Text] [Related]
37. Hereditary angioedema with normal C1-inhibitor activity in women.
Bork K; Barnstedt SE; Koch P; Traupe H
Lancet; 2000 Jul; 356(9225):213-7. PubMed ID: 10963200
[TBL] [Abstract][Full Text] [Related]
38. Type II hereditary angio-oedema associated with two mutations in one allele of the C1-inhibitor gene around the reactive-site coding region.
Siddique Z; McPhaden AR; Whaley K
Hum Hered; 1992; 42(5):298-301. PubMed ID: 1459574
[TBL] [Abstract][Full Text] [Related]
39. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course.
Bork K; Gül D; Hardt J; Dewald G
Am J Med; 2007 Nov; 120(11):987-92. PubMed ID: 17976427
[TBL] [Abstract][Full Text] [Related]
40. Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.
Verpy E; Couture-Tosi E; Eldering E; Lopez-Trascasa M; Späth P; Meo T; Tosi M
J Clin Invest; 1995 Jan; 95(1):350-9. PubMed ID: 7814636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]